ProMIS Neurosciences, Inc. (PMN)
NASDAQ: PMN · Real-Time Price · USD
10.39
-0.19 (-1.80%)
At close: May 15, 2026, 4:00 PM EDT
10.50
+0.11 (1.06%)
After-hours: May 15, 2026, 4:10 PM EDT
ProMIS Neurosciences Employees
As of December 31, 2025, ProMIS Neurosciences had 11 total employees, including 10 full-time and 1 part-time employees. The number of employees increased by 3 or 37.50% compared to the previous year.
Employees
11
Change (1Y)
3
Growth (1Y)
37.50%
Revenue / Employee
n/a
Profits / Employee
-$3,692,329
Market Cap
93.17M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 11 | 3 | 37.50% | 10 | 1 |
| Dec 31, 2024 | 8 | 1 | 14.29% | 7 | 1 |
| Dec 31, 2023 | 7 | 0 | - | 6 | 1 |
| Dec 31, 2022 | 7 | 1 | 16.67% | 6 | 1 |
| Dec 31, 2021 | 6 | 5 | 500.00% | 5 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| Seer, Inc. | 124 |
| Cibus | 118 |
| Pelthos Therapeutics | 92 |
| Vivani Medical | 42 |
| Biomea Fusion | 41 |
| Aardvark Therapeutics | 40 |
| Oncolytics Biotech | 29 |
PMN News
- 5 days ago - ProMIS Neurosciences reports Q1 EPS ($1.26) vs. ($5.27) last year - TheFly
- 5 days ago - ProMIS Neurosciences Announces First Quarter 2026 Financial Results and Provides Corporate Highlights - GlobeNewsWire
- 4 weeks ago - ProMIS Neurosciences Invited to Participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference - Newsfile Corp
- 7 weeks ago - ProMIS Neurosciences files $200M mixed securities shelf - TheFly
- 7 weeks ago - ProMIS Neurosciences Announces Full Year 2025 Financial Results and Provides Corporate Highlights - GlobeNewsWire
- 2 months ago - ProMIS Neurosciences files to sell 13.83M common shares for holders - TheFly
- 2 months ago - ProMIS Neurosciences to Present Data on ALS & Parkinsons Disease Programs at Alzheimer's Disease/Parkinson's Disease 2026 International Conference (AD/PD™) - GlobeNewsWire
- 3 months ago - ProMIS Neurosciences Transcript: Guggenheim Securities Emerging Outlook: Biotech Summit 2026 - Transcripts